<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-06-02T00:34:40Z</responseDate><request verb="GetRecord" identifier="oai:riuma.uma.es:10630/25676" metadataPrefix="qdc">https://riuma.uma.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:riuma.uma.es:10630/25676</identifier><datestamp>2026-02-03T11:52:22Z</datestamp><setSpec>com_10630_2254</setSpec><setSpec>col_10630_37959</setSpec></header><metadata><qdc:qualifieddc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>The absence of microbiota dysbiosis is essential to maintain a healthy immune system in cancer patients</dc:title>
   <dc:creator>Burgos-Molina, Antonio Manuel</dc:creator>
   <dc:creator>González Vidal, Alejandro</dc:creator>
   <dc:creator>Alamilla Presuel, Juan Carlos</dc:creator>
   <dc:creator>Mercado-Sáenz, Silvia</dc:creator>
   <dc:creator>Ruiz-Gómez, Miguel José</dc:creator>
   <dc:subject>Inmunidad</dc:subject>
   <dc:subject>Cáncer - Tratamiento</dc:subject>
   <dcterms:abstract>Gut microbiota is required for mucosal immunity. The intestinal mucosa is the main location for microbiome-host interactions. The dynamic interaction between microbiome and environmental factors modulate mucosal and systemic immunity. The absence of dysbiosis contributes to the good health of the immune system, leading to a better response to treatment in cancer patients.</dcterms:abstract>
   <dcterms:dateAccepted>2022-12-23T08:01:53Z</dcterms:dateAccepted>
   <dcterms:available>2022-12-23T08:01:53Z</dcterms:available>
   <dcterms:created>2022-12-23T08:01:53Z</dcterms:created>
   <dcterms:issued>2022</dcterms:issued>
   <dc:type>conference output</dc:type>
   <dc:identifier>https://hdl.handle.net/10630/25676</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>18th ASEICA INTERNATIONAL CONGRESS</dc:relation>
   <dc:relation>Santiago de Compostela, España.</dc:relation>
   <dc:relation>16 al 18 de Noviembre 2022</dc:relation>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
   <dc:rights>open access</dc:rights>
   <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 Internacional</dc:rights>
</qdc:qualifieddc>
</metadata></record></GetRecord></OAI-PMH>